Skip to main content

More About Jorjani

Image result for Heidegger

My first impression about Jorjani was that he sounded like Heidegger.

I'm happy to report that my instincts did not betray me: he cites Heidegger as in influence in this strange article: https://www.righton.net/2016/11/05/world-religion-of-the-future/

As you can see if you follow that link, the article appears on a website called  "RightOn" which proudly calls itself reactionary, promising to put the "action" in "reactionary."

Let's use this to look at Jorjani a bit. The article is called "The World Religion of the Future." It kicks off with Heidegger, and a story about a Japanese student of his, who in 1919 introduced Heidegger to
aspects of Zen Buddhism.

Then there's a long bit in which Jorjani is just quoting and sometimes paraphrasing Leo Strauss on Heidegger, without giving us any clue whether he thinks Strauss was right. Then we're really just trying to hold on tight as a train of thought zigs and zags through the mountain passes. The Indian caste system, Descartes,  Nishida Kitaro, Dostoevsky, etc. All signifiers of "I've read everything and thought about everything."

But if I understand it at all, the key points of the article can be phrased simply:

1. There will be a single global state -- the fact is inevitable, resistance is futile;
2. The single global state will need a single globally dominant religion;
3.  This ought not to be any of the three religions that trace themselves back to Abraham, because they have all sold themselves out to a "soulless global marketplace."
4. In order to devise a world religion that has some soul and can serve in a market-transcending way the need of the coming global empire, one needs to syncretize Japanese traditions involving Zen with the Indian caste system and the German culture as reflected in Heidegger's work.

Thoroughly ugly stuff. Of course, Japan and Germany were once allied in a struggle for world domination. India? Well ... throwing in India helps sanitize the swastika, and the reference to the caste system suggests that some people are just naturally better than others, born that way: which presumably will be recognized by the world religion of the future.

India was of course part of the British Empire when Japan and Germany were allied. There was a strong Independence sentiment at the time, and independence would become a fact not long after the war. So yes there were Indians who out of principled pacifism and/or a refusal to serve their own colonial overlords, refused to co-operate with resistance to the Japanese.

Nonetheless, there were also many Indians who fought bravely against the Axis powers, notably in the two-week battle of Kohima and Imphal. This battle (or these two simultaneous battles -- as the name indicates that's a matter of interpretation) represented Japan's furthest push westward, and the moment when the rising sun were thrown back below this particular horizon. This was the "Midway" of the BIC theater. And nearly all the troops throwing the Japanese back were Indian.

Relatedly, perhaps, there are two different sorts of swastika, a fact Jorjani doesn't mention. The crooked arms can turn in one direction or the other.

And, yes, the idea of a single global state can and should be resisted. In large part it must be resisted because of the reasonable fear that people like Jorjani and his idols will end up running it. There must never exist the concentration of power such a presumption implies. 


Comments

Popular posts from this blog

A Story About Coleridge

This is a quote from a memoir by Dorothy Wordsworth, reflecting on a trip she took with two famous poets, her brother, William Wordsworth, and their similarly gifted companion, Samuel Taylor Coleridge.



We sat upon a bench, placed for the sake of one of these views, whence we looked down upon the waterfall, and over the open country ... A lady and gentleman, more expeditious tourists than ourselves, came to the spot; they left us at the seat, and we found them again at another station above the Falls. Coleridge, who is always good-natured enough to enter into conversation with anybody whom he meets in his way, began to talk with the gentleman, who observed that it was a majestic waterfall. Coleridge was delighted with the accuracy of the epithet, particularly as he had been settling in his own mind the precise meaning of the words grand, majestic, sublime, etc., and had discussed the subject with William at some length the day before. “Yes, sir,” says Coleridge, “it is a majestic wate…

Hume's Cutlery

David Hume is renowned for two pieces of cutlery, the guillotine and the fork.

Hume's guillotine is the sharp cut he makes between "is" statements and "ought" statements, to make the point that the former never ground the latter.

His "fork" is the division between what later came to be called "analytic" and "synthetic" statements, with the ominous observation that any books containing statements that cannot be assigned to one or the other prong should be burnt.

Actually, I should acknowledge that there is some dispute as to how well or poorly the dichotomy Hume outlines really maps onto the analytic/synthetic dichotomy. Some writers maintain that Hume meant something quite different and has been hijacked. Personally, I've never seen the alleged difference however hard they've worked to point it out to me.

The guillotine makes for a more dramatic graphic than a mere fork, hence the bit of clip art above.

I'm curious whe…

Cancer Breakthrough

Hopeful news in recent days about an old and dear desideratum: a cure for cancer. Or at least for a cancer, and a nasty one at that.

The news comes about because investors in GlaxoSmithKline are greedy for profits, and has already inspired a bit of deregulation to boot. 

The FDA has paved the road for a speedy review of a new BCMA drug for multiple myeloma, essentially cancer of the bone marrow. This means that the US govt has removed some of the hurdles that would otherwise (by decision of the same govt) face a company trying to proceed with these trials expeditiously. 

This has been done because the Phase I clinical trial results have been very promising. The report I've seen indicates that details of these results will be shared with the world on Dec. 11 at the annual meeting of the American Society of Hematology. 

The European Medicines Agency has also given priority treatment to the drug in question. 

GSK's website identifies the drug at issue as "GSK2857916," althou…